CoChat

Neurobiology of antidepressant withdrawal: implications for the longitudinal outcome of depression

Harvey, Brian H, McEwen, Bruce S, Stein, Dan J · 2003 · Biological Psychiatry
Cited by 65

The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.

Abstract

Inappropriate discontinuation of drug treatment and noncompliance are a leading cause of long-term morbidity during treatment of depression. Increasing evidence supports an association between depressive illness and disturbances in brain glutamate activity, nitric oxide synthesis, and gamma-amino butyric acid. Animal models also confirm that suppression of glutamate N-methyl-D-aspartate receptor activity or inhibition of the nitric oxide-cyclic guanosine monophosphate pathway, as well as increasing brain levels of gamma-amino butyric acid, may be key elements in antidepressant action. Imaging studies demonstrate, for the most part, decreased hippocampal volume in patients with depression, which may worsen with recurrent depressive episodes. Preclinical models link this potentially neurodegenerative pathology to continued stress-evoked synaptic remodeling, driven primarily by the release of glucocorticoids, glutamate, and nitric oxide. These stress-induced structural changes can be reversed by antidepressant treatment. In patients with depression, antidepressant withdrawal after chronic administration is associated with a stress response as well as functional and neurochemical changes. Preclinical data also show that antidepressant withdrawal evokes a behavioral stress response that is associated with increased hippocampal N-methyl-D-aspartate receptor density, with both responses dependent on N-methyl-D-aspartate receptor activation. Drawing from both clinical and preclinical studies, this article proposes a preliminary molecular perspective and hypothesis on the neuronal implications of adherence to and discontinuation of antidepressant medication.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0006-3223(03)00528-6

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 33 references

Research works printed but not linked: 96

  1. Abercrombie, 1998, Metabolic rate in the right amygdala predicts negative affect in depressed patients, Neuroreport, 9, 3301, 10.1097/00001756-199810050-00028 · DOI · Paper page
  2. Altshuler, 1998, Amygdala enlargement in bipolar disorder and hippocampal reduction in schizophrenia, Arch Gen Psychiatry, 55, 663
  3. Anthony, 2000, Antidepressant-induced regulation of 5HT1B mRNA in rat dorsal raphe nucleus reverses rapidly after drug discontinuation, J Neurosci Res, 61, 82, 10.1002/1097-4547(20000701)61:1<82::AID-JNR10>3.0.CO;2-E · DOI
  4. Basco, 1995, Compliance of pharmacotherapy in mood disorder, Psychiatr Ann, 25, 269, 10.3928/0048-5713-19950501-03 · DOI
  5. Bell, 2001, Tryptophan depletion and its implications for psychiatry, Br J Psychiatry, 178, 399, 10.1192/bjp.178.5.399 · DOI · Paper page
  6. Berk, 2001, Platelet glutamate receptor supersensitivity in major depressive disorder, Clin Neuropharmacol, 24, 129, 10.1097/00002826-200105000-00002 · DOI
  7. Bernstein, 1998, Nitric oxide synthase-containing neurons in the human hypothalamus, Neuroscience, 83, 867, 10.1016/S0306-4522(97)00461-2 · DOI · Paper page
  8. Bourdeau, 2002, Loss of brain volume in endogenous Cushing’s syndrome and its reversibility after correction of hypercortisolism, J Clin Endocrinol Metab, 87, 1949
  9. Boyer, 1998, Chronic administration of imipramine and citalopram alters the expression of NMDA receptor subunit mRNAs in mouse brain, J Mol Neurosci, 10, 219, 10.1007/BF02761776 · DOI
  10. Chrousos, 1992, The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis, JAMA, 267, 1244, 10.1001/jama.1992.03480090092034 · DOI · Paper page
  11. Czeh, 2001, Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine, Proc Natl Acad Sci U S A, 98, 12796, 10.1073/pnas.211427898 · DOI · Paper page
  12. Dall’Olio, 2000, D-cycloserine, a positve modulator of NMDA receptors, inhibits serotonergic function, Behav Pharmacol, 11, 631, 10.1097/00008877-200011000-00010 · DOI
  13. de Oliviera, 2000, Expression of neuronal nitric oxide synthase mRNA in stress-related brain areas after restraint in rats, Neurosci Lett, 289, 123, 10.1016/S0304-3940(00)01287-8 · DOI
  14. De Paermentier, 1997, Brain alpha-adrenoceptors in depressed suicides, Brain Res, 757, 60, 10.1016/S0006-8993(97)00138-8 · DOI
  15. Di Cara, 2001, Serotonin depletion produces long-lasting increase in striatal glutamatergic transmission, J Neurochem, 78, 240, 10.1046/j.1471-4159.2001.00242.x · DOI
  16. Dilsaver, 1989, Antidepressant withdrawal syndromes, Acta Psychiatr Scand, 79, 113, 10.1111/j.1600-0447.1989.tb08578.x · DOI · Paper page
  17. Dowlatshahi, 1999, G Protein-coupled cyclic AMP signaling in postmortem brain of subjects with mood disorders, J Neurochem, 73, 1121, 10.1046/j.1471-4159.1999.0731121.x · DOI
  18. Dowlatshahi, 1998, Increased temporal cortex CREB concentrations and antidepressant treatment in major depression, Lancet, 352, 1754, 10.1016/S0140-6736(05)79827-5 · DOI · Paper page
  19. Drevets, 1997, Subgenual prefrontal cortex abnormalities in mood disorders, Nature, 386, 824, 10.1038/386824a0 · DOI · Paper page
  20. D’Sa, 2002, Antidepressants and neuroplasticity, Bipolar Disord, 4, 184
  21. Engelmann, 2002, Release patterns of excitatory and inhibitory amino acids within the hypothalamic supraoptic nucleus in response to direct nitric oxide administration during forced swimming in rats, Neurosci Lett, 324, 252, 10.1016/S0304-3940(02)00211-2 · DOI
  22. Golembiowska, 2000, Effect of acute and chronic administration of citalopram on glutamate and aspartate release in the rat prefrontal cortex, Pol J Pharmacol, 52, 441
  23. Greden, 1993, Antidepressant maintenance medications, J Clin Psychiatry, 54, 39
  24. Harkin, 2000, Noradrenergic lesion antagonises desimipramine-induced adaptation of NMDA receptors, Eur J Pharmacol, 389, 187, 10.1016/S0014-2999(99)00923-1 · DOI
  25. Harkin, 1999, Nitric oxide synthase inhibitors have antidepressant-like properties in mice, Eur J Pharmacol, 372, 207, 10.1016/S0014-2999(99)00191-0 · DOI · Paper page
  26. Harvey, 1996, Affective disorders and nitric oxide, Hum Psychopharmacol, 11, 309, 10.1002/(SICI)1099-1077(199607)11:4<309::AID-HUP775>3.0.CO;2-B · DOI
  27. Harvey, 1997, The neurobiology and pharmacology of depression, S Afr Med J, 87, 540
  28. Harvey, 2002, NMDA receptor involvement in imipramine withdrawal-associated effects on swim stress, GABA levels and NMDA receptor binding in rat hippocampus, Life Sci, 71, 43, 10.1016/S0024-3205(02)01561-8 · DOI · Paper page
  29. Heiberg, 2002, Reduction of cGMP and nitric oxide has antidepressant-like effects in the forced swimming test in rats, Behav Brain Res, 134, 479, 10.1016/S0166-4328(02)00084-0 · DOI
  30. Henry, 2003, Cerebral blood volume and clinical changes on the third day of placebo substitution for SSRI treatment, Biol Psychiatry, 53, 100, 10.1016/S0006-3223(02)01441-5 · DOI
  31. Ichimiya, 2002, Serotonin transporter binding in patients with mood disorders, Biol Psychiatry, 51, 715, 10.1016/S0006-3223(01)01351-8 · DOI · Paper page
  32. Ishizuka, 2000, GABA(A) and GABA(B) receptors modulating basal and footshock-induced nitric oxide releases in rat prefrontal cortex, Brain Res, 872, 266, 10.1016/S0006-8993(00)02508-7 · DOI
  33. Izumi, 2002, Glutamate transporters and retinal excitotoxicity, Glia, 39, 58, 10.1002/glia.10082 · DOI
  34. Kasper, 2002, Receptor and transporter imaging studies in schizophrenia, depression, bulimia and Tourette’s disorder-implications for psychopharmacology, World J Biol Psychiatry, 3, 133, 10.3109/15622970209150614 · DOI · Paper page
  35. Kaufman MJ, Henry ME, Blaise F, Hennen J, Villafurete RA, Stoddard E, et al (2003): Selective serotonin reuptake inhibitor discontinuation syndrome is associated with a rostral anterior cingulate choline metabolite decrease: A proton magnetic resonance spectroscopic imaging study. Biol Psychiatry 54:534–539 · DOI
  36. Keller, 1998, Implications of failing to achieve successful long-term maintenance treatment of recurrent unipolar major depression, Biol Psychiatry, 44, 348, 10.1016/S0006-3223(98)00110-3 · DOI · Paper page
  37. Keller, 2002, Optimizing outcomes in depression, Int Clin Psychopharmacol, 17, 265, 10.1097/00004850-200211000-00001 · DOI · Paper page
  38. Kim, 2002, Changes of GABAA receptor binding and subunit mRNA level in rat brain by infusion of NOS inhibitor, Brain Res, 952, 246, 10.1016/S0006-8993(02)03248-1 · doi:10.1016/s0006-8993(02)03248-1
  39. Kroczka, 2001, Antidepressant-like properties of zinc in rodent forced swim test, Brain Res Bull, 55, 297, 10.1016/S0361-9230(01)00473-7 · DOI · Paper page
  40. Krukoff, 1997, Stress-induced activation of nitric oxide-producing neurons in the rat brain, J Comp Neurol, 377, 509, 10.1002/(SICI)1096-9861(19970127)377:4<509::AID-CNE3>3.0.CO;2-6 · DOI
  41. Kuhn, 2002, Chronic course and psychosocial disability caused by depressive illnesses in general practice patients during a one year period. Results of a study by the World Health Organization, Nervenarzt, 73, 644
  42. Law, 2001, Asymmetrical reductions of hippocampal NMDAR1 glutamate receptor mRNA in the psychoses, Neuroreport, 12, 2971, 10.1097/00001756-200109170-00043 · DOI · Paper page
  43. Lee, 2001, Fluoxetine enhances cell proliferation and prevents apoptosis in dentate gyrus of maternally separated rats, Mol Psychiatry, 6, 725, 10.1038/sj.mp.4000947 · DOI · Paper page
  44. Lievens, 2001, Impaired glutamate uptake in the R6 Huntington’s disease transgenic mice, Neurobiol Dis, 8, 807, 10.1006/nbdi.2001.0430 · DOI · Paper page
  45. Lowy, 1993, Adrenalectomy attenuates stress-induced elevations in extracellular glutamate concentrations in the hippocampus, J Neurochem, 61, 1957, 10.1111/j.1471-4159.1993.tb09839.x · DOI · Paper page
  46. Lucassen, 2001, Hippocampal apoptosis in major depression is a minor event and absent from subareas at risk for glucocorticoid overexposure, Am J Pathol, 158, 453, 10.1016/S0002-9440(10)63988-0 · DOI · Paper page
  47. Maes, 1994, Hypozincemia in depression, J Affect Disord, 31, 135, 10.1016/0165-0327(94)90117-1 · DOI · Paper page
  48. Maes, 1998, Serum levels of excitatory amino acids, serine, glycine, histidine, threonine, taurine, alanine and arginine in treatment-resistant depression, Acta Psychiatr Scand, 97, 302, 10.1111/j.1600-0447.1998.tb10004.x · DOI · Paper page
  49. Malberg, 1999, Chronic antidepressant administration increases granule cell proliferation in the hippocampus of the adult male rat, Abstr Soc Neurosci, 25, 1029
  50. Manier, 2000, Human fibroblasts as a relevant model to study signal transduction in affective disorders, J Affect Disord, 61, 51, 10.1016/S0165-0327(99)00190-1 · DOI
  51. Matute, 2001, The link between excitotoxic oligodendroglial death and demyelinating diseases, Trends Neurosci, 24, 224, 10.1016/S0166-2236(00)01746-X · DOI · Paper page
  52. Mauri, 1998, Plasma and platelet amino acid concentrations in patients affected by major depression and under fluvoxamine treatment, Neuropsychobiology, 37, 124, 10.1159/000026491 · DOI · Paper page
  53. McCullumsmith, 2002, Striatal excitatory amino acid transporter transcript expression in schizophrenia, bipolar disorder, and major depressive disorder, Neuropsychopharmacology, 26, 368, 10.1016/S0893-133X(01)00370-0 · DOI · Paper page
  54. McEwen, 2000, The neurobiology of stress, Brain Res, 886, 172, 10.1016/S0006-8993(00)02950-4 · DOI · Paper page
  55. McEwen, 1997, Prevention of stress-induced morphological and cognitive consequences, Eur Neuropsychopharmacol, 7, 323, 10.1016/S0924-977X(97)00064-3 · DOI
  56. McLeod, 2001, Nitric oxide, stress, and depression, Psychopharmacol Bull, 35, 24
  57. Mervaala, 2000, Quantitative MRI of the hippocampus and amygdala in severe depression, Psychol Med, 30, 117, 10.1017/S0033291799001567 · DOI · Paper page
  58. Michelson, 2000, Hormonal markers of stress response following interruption of selective serotonin reupake inhibitor treatment, Psychoneuroendocrinology, 25, 169, 10.1016/S0306-4530(99)00046-3 · DOI
  59. Miller, 1994, Adenosine A3 receptors regulate serotonin transport via nitric oxide and cGMP, J Biol Chem, 269, 27351, 10.1016/S0021-9258(18)46992-X · DOI · Paper page
  60. Mischoulon, 2002, An open lable pilot study of nefazodone in depression with anger attacks, Psychiatry Res, 116, 151, 10.1016/S0925-4927(02)00082-3 · DOI
  61. Miyamoto, 2002, Lower sensitivity to stress and altered monoaminergic neuronal function in mice lacking the NMDA receptor epsilon 4 subunit, J Neurosci, 22, 2335, 10.1523/JNEUROSCI.22-06-02335.2002 · DOI · Paper page
  62. Moore, 2000, Lithium increases N-acetyl-aspartate in the human brain, Biol Psychiatry, 48, 1, 10.1016/S0006-3223(00)00252-3 · DOI · Paper page
  63. Nierenberg, 2001, Long-term management of chronic depression, J Clin Psychiatry, 62, 17
  64. Nowak, 1995, Alterations in the N-methyl-D-aspartate (NMDA) receptor complex in the frontal cortex of suicide victims, Brain Res, 675, 157, 10.1016/0006-8993(95)00057-W · DOI · Paper page
  65. Ohkuma, 1995, Nitric oxide-induced, J Neurochem, 65, 1109, 10.1046/j.1471-4159.1995.65031109.x · doi:10.1046/j.1471-4159.1995.65031109.x
  66. Pandey, 1997, Benzodiazepine receptors in the post-mortem brain of suicide victims and schizophrenic subjects, Psychiatry Res, 71, 137, 10.1016/S0165-1781(97)00060-7 · DOI
  67. Paul, 2001, Antidepressant activity and calcium signaling cascades, Hum Psychopharmacol, 16, 71, 10.1002/hup.186 · DOI
  68. Pawlak, 2003, Tissue plasminogen activator in the amygdala is critical for stress-induced anxiety-like behavior, Nat Neurosci, 6, 168, 10.1038/nn998 · DOI · Paper page
  69. Pham, 2003, Repeated restraint stress suppresses neurogenesis and induces biphasic PSA-NCAM expression in the adult rat dentate gyrus, Eur J Neurosci, 17, 1, 10.1046/j.1460-9568.2003.02513.x · DOI · Paper page
  70. Popoli, 2002, Modulation of synaptic plasticity by stress and antidepressants, Bipolar Disord, 4, 166, 10.1034/j.1399-5618.2002.01159.x · DOI
  71. Post, 1998, Sensitization and kindling phenomena in mood, anxiety, and obsessive-compulsive disorders, Biol Psychiatry, 44, 193, 10.1016/S0006-3223(98)00144-9 · DOI · Paper page
  72. Rajkowska, 2000, Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells, Biol Psychiatry, 48, 766, 10.1016/S0006-3223(00)00950-1 · DOI · Paper page
  73. Rao, 2001, Antisense knockdown of the glial glutamate transporter GLT-1 exacerbates hippocampal neuronal damage following traumatic injury to rat brain, Eur J Neurosci, 13, 119
  74. Rasmussen, 2002, Downregulation of BDNF mRNA in the hippocampal dentate gyrus after re-exposure to cues previously associated with footshock, Neuropsychopharmacology, 27, 133, 10.1016/S0893-133X(02)00286-5 · DOI · Paper page
  75. Rogoz, 2002, Synergistic effects of uncompetitive NMDA receptor antagonists and antidepressant drugs in the forced swimming test in rats, Neuropharmacology, 42, 1024, 10.1016/S0028-3908(02)00055-2 · DOI · Paper page
  76. Saransaari, 1997, Enhanced GABA release in cell-damaging conditions in the adult and developing mouse hippocampus, Int J Dev Neurosci, 15, 163, 10.1016/S0736-5748(97)80001-9 · DOI
  77. Schatzberg, 1997, Possible biological mechanisms of the serotonin reuptake inhibitor discontinuation syndrome, J Clin Psychiatry, 58, 23
  78. Shiah, 1998, GABA function in mood disorders, Life Sci, 63, 1289, 10.1016/S0024-3205(98)00241-0 · DOI
  79. Skolnick, 1999, Antidepressants for the new millenium, Eur J Pharmacol, 375, 31, 10.1016/S0014-2999(99)00330-1 · DOI · Paper page
  80. Skolnick, 1996, Adaptation of N-methyl-D-aspartate receptors following antidepressant treatment, Pharmacopsychiatry, 29, 23, 10.1055/s-2007-979537 · DOI · Paper page
  81. Smith, 1995, Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus, J Neurosci, 15, 1768, 10.1523/JNEUROSCI.15-03-01768.1995 · DOI · Paper page
  82. Spadone, 2002, Treatment adherence in the recurrent depressive disorders, Encephale, 28, 255
  83. Starkman, 2001, Elevated cortisol levels in Cushings disease are associated with cognitive decrements, Psychosom Med, 63, 985, 10.1097/00006842-200111000-00018 · DOI · Paper page
  84. Starkman, 2003, Improvement in learning associated with increase in hippocampal formation volume, Biol Psychiatry, 53, 233, 10.1016/S0006-3223(02)01750-X · DOI
  85. Stewart, 2002, Antidepressant mechanisms, Mol Psychiatry, 7, S15, 10.1038/sj.mp.4001014 · DOI
  86. Strakowski, 1999, Brain magnetic resonance imaging of structural abnormalities in bipolar disorder, Arch Gen Psychiatry, 56, 254, 10.1001/archpsyc.56.3.254 · DOI · Paper page
  87. Stryjer, 2003, Amantadine as augmentation therapy in the management of treatment resistant depression, Int Clin Psychopharmacol, 18, 93, 10.1097/00004850-200303000-00005 · DOI
  88. Sullivan, 2001, Heritability of hippocampal size in elderly men, Hippocampus, 11, 754, 10.1002/hipo.1091 · DOI · Paper page
  89. Suzuki, 2001, Elevated plasma nitrate levels in depressive states, J Affect Disord, 63, 221, 10.1016/S0165-0327(00)00164-6 · DOI · Paper page
  90. Tagliaferro, 2001, Increased nitric oxide synthase activity in a model of serotonin depletion, Brain Res Bull, 54, 199, 10.1016/S0361-9230(00)00450-0 · DOI
  91. Vaidya, 1999, Role of 5HT2A receptors in the stress-induced down-regulation of brain-derived neurotrophic factor expression in rat hippocampus, Neurosci Lett, 262, 1, 10.1016/S0304-3940(99)00006-3 · DOI · Paper page
  92. Wegener, 2000, Endogenous nitric oxide decreases hippocampal levels of serotonin and dopamine in vivo, Br J Pharmacol, 130, 575, 10.1038/sj.bjp.0703349 · DOI · Paper page
  93. Xing, 2002, Decreased calcium-dependent constitutive nitric oxide synthase (cNOS) activity in prefrontal cortex in schizophrenia and depression, Schizophr Res, 58, 21, 10.1016/S0920-9964(01)00388-7 · DOI
  94. Yamada, 1999, GABAB receptor-mediated presynaptic inhibition of glutamatergic and GABA’ergic transmission in the basolateral amygdala, Neuropharmacology, 38, 1743, 10.1016/S0028-3908(99)00126-4 · DOI
  95. Yuan, 2000, Apoptosis in the nervous system, Nature, 407, 802, 10.1038/35037739 · DOI · Paper page
  96. Zetterström, 1999, Manipulations of brain 5HT levels affect gene expression for BDNF in rat brain, Neuropharmacology, 38, 1063, 10.1016/S0028-3908(99)00022-2 · DOI

Cited by

See all 65

Metadata

Authors
Harvey, B. H., McEwen, B. S., & Stein, D. J.
Venue
Biological Psychiatry
Publisher
Elsevier BV
Published
2003-11
Volume
54
Issue
10
Pages
1105-1117
ISSN
0006-3223 (ISSN-L)
OpenAlex
W2013321343
Cited by
65
References
33
FWCI
3.99
Type
journal article
Language
en
Open access
closed
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Funders
  • South African Medical Research Council
  • National Research Foundation of Korea (2053203)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Neurobiology of antidepressant withdrawal: implications for the longitudinal outcome of depression. https://app.cochat.ai/papers/10.1016/s0006-3223(03)00528-6
The paper
Harvey, B. H., McEwen, B. S., & Stein, D. J. (2003). Neurobiology of antidepressant withdrawal: implications for the longitudinal outcome of depression. Biological Psychiatry. https://doi.org/10.1016/s0006-3223(03)00528-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.